Tranexamic acid for safer surgery: the time is now.
bleeding
clinical trial
surgery
thromboembolic events
tranexamic acid
Journal
British journal of anaesthesia
ISSN: 1471-6771
Titre abrégé: Br J Anaesth
Pays: England
ID NLM: 0372541
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
14
06
2022
revised:
22
06
2022
accepted:
24
06
2022
pubmed:
8
9
2022
medline:
6
10
2022
entrez:
7
9
2022
Statut:
ppublish
Résumé
Tranexamic acid reduces surgical bleeding. Consistent with previous research, the POISE-3 (Peri-Operative Ischemic Evaluation-3) trial found that tranexamic acid reduces major bleeding by 25% and with a low probability of any increase in thromboembolic events. Wider tranexamic acid use will improve surgical safety, avoid unnecessary blood use, reduce the risk of transfusion transmitted infections, and save healthcare funds. 'Consideration of tranexamic acid use' should be included in the safe surgery checklist. We have the evidence, and we need to act on it.
Identifiants
pubmed: 36070986
pii: S0007-0912(22)00344-0
doi: 10.1016/j.bja.2022.06.024
pii:
doi:
Substances chimiques
Tranexamic Acid
6T84R30KC1
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
459-461Subventions
Organisme : Medical Research Council
ID : MR/M009211/1
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.